Seven spin-off companies have been created from CTB research, transferring biomedical technologies from the laboratory to the market.
Surface modification of materials to enhance biocompatibility. Functionalization of AFM probes to increase the resolution and applications of atomic force microscopy. Founded 30 June 2020.
In vitro diagnostic Point-of-Care (PoC) devices for rapid and sensitive detection of clinical biomarkers. Founded 19 February 2010.
Software and services for human voice analysis, including pathological voice detection, speaker identification and vocal health monitoring systems. Founded 5 July 2011.
Neuroscience applied to business strategy, marketing and human resources. Uses EEG and cognitive neuroscience methods to optimise decision-making in organisational contexts. Founded 6 October 2016.
Audiometric systems and hearing screening devices based on neuromorphic signal processing and voice analysis technology from the NeuVox laboratory. Founded 14 March 2013.
Technologies for promoting healthy ageing. Development of devices and digital solutions to support active ageing and fall prevention in older adults. Founded 9 September 2021.
Distribution and clinical validation of biomedical devices developed at the CTB. Specialises in translating lab prototypes to clinical-grade products. Founded 18 December 2015.
Low-field magnetic stimulation devices and dosimeters for non-invasive medical applications and therapeutic magnetic field generation. Founded 30 October 2009.
New medical therapies based on biomaterials from silk proteins, including silk fibroin scaffolds for tissue engineering and regenerative medicine. Founded 5 December 2016.